About the Authors
- Antoaneta A. Markova
-
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
- Ulrike Mihm
-
Affiliation Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany
- Verena Schlaphoff
-
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
- Sebastian Lunemann
-
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
- Natalie Filmann
-
Affiliation Institute of Biostatistics and Mathematical Modelling, Faculty of Medicine, JW Goethe-University, Frankfurt am Main, Germany
- Birgit Bremer
-
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
- Thomas Berg
-
Affiliation Department of Internal Medicine, Division of Gastroenterology and Rheumatology, University of Leipzig, Leipzig, Germany
- Christoph Sarrazin
-
Affiliation Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany
- Stefan Zeuzem
-
Affiliation Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany
- Michael P. Manns
-
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
- Markus Cornberg
-
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
- Eva Herrmann
-
Affiliation Institute of Biostatistics and Mathematical Modelling, Faculty of Medicine, JW Goethe-University, Frankfurt am Main, Germany
- Heiner Wedemeyer
-
* E-mail: Wedemeyer.Heiner@mh-hannover.de
Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
Competing Interests
AM, UM, VS, SL, NF, BB, CS, EH and TB have declared that no competing interests exist. SZ: Consultancies for AbbVie, BMS, Boehringer, Gilead, Idenix, Janssen, Merck, Novartis, Roche, Santaris, Verte. MC: Lecture fees from Roche, Merck (MSD), Gilead, Boehringer, BMS, Falk Consultant fees from Roche, Merck (MSD), Gilead, Novartis, Boehringer Reseach support from Roche, Merck (MSD), Gilead. MPM: Consultant/Lecture fees from Abbott, Abbie, BMS, Boehringer, Falk, Gilead, JJ/Janssen-Cilag, MSD, Norgine, Novartis, Roche, Roche Diagnostics, Siemens. HW: Consultant/Lecture fees from Abbott, Abbie, Biolex, BMS, Boehringer, Falk, Gilead, ITS, JJ/Janssen-Cilag, Medgenetics, MSD, Norgine, Novartis, Roche, Roche Diagnostics, Siemens, Transgene, ViiV. Reseach support from Abbott, BMS, Gilead, Merck, Novartis, Roche, Roche Diagnostics, Siemens. The authors confirm that co-author Heiner Wedemeyer is a PLOS ONE Editorial Board member. The authors confirm that this does not alter your adherence to PLOS ONE Editorial policies and criteria. The authors confirm the relationships to the sponsor Roche Germany did not alter the adherence of the authors to all PLOS ONE policies on sharing data and materials, as detailed online in the PlosOne our guide for authors.
Author Contributions
Conceived and designed the experiments: AM VS HW. Performed the experiments: AM VS BB. Analyzed the data: AM VS SL CS NF EH HW. Contributed reagents/materials/analysis tools: UM TB CS SZ MPM. Wrote the paper: AM VS SL MC MPM EH HW.